Kinetics of humoral response to ALK and its relationship with minimal residual disease in pediatric ALCL

Leukemia. 2009 Feb;23(2):400-2. doi: 10.1038/leu.2008.184. Epub 2008 Jul 10.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Anaplastic Lymphoma Kinase
  • Antibodies / blood
  • Antibody Formation*
  • Child
  • Child, Preschool
  • Humans
  • Infant
  • Kinetics
  • Lymphoma, Large-Cell, Anaplastic / diagnosis
  • Lymphoma, Large-Cell, Anaplastic / drug therapy
  • Lymphoma, Large-Cell, Anaplastic / immunology*
  • Neoplasm, Residual / diagnosis*
  • Neoplasm, Residual / immunology
  • Nuclear Proteins / immunology
  • Nucleophosmin
  • Oncogene Proteins, Fusion / immunology
  • Protein-Tyrosine Kinases / immunology*
  • Receptor Protein-Tyrosine Kinases

Substances

  • Antibodies
  • Nuclear Proteins
  • Oncogene Proteins, Fusion
  • Nucleophosmin
  • ALK protein, human
  • Anaplastic Lymphoma Kinase
  • Protein-Tyrosine Kinases
  • Receptor Protein-Tyrosine Kinases